Consistent with the amyloid/tau/neurodegeneration (ATN) framework, we observed early amyloid pathology reflected by reductions in the plasma Aβ42/40 ratio, which aligns with the well‐established amyloid hypothesis.53 This evidence concerns the gene MAPT and amyloidosis.